ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression - PubMed (original) (raw)
. 2006 Jul 6;442(7098):96-9.
doi: 10.1038/nature04835. Epub 2006 May 21.
Tao Hong, Kay L Walter, Mark Ewalt, Eriko Michishita, Tiffany Hung, Dylan Carney, Pedro Peña, Fei Lan, Mohan R Kaadige, Nicolas Lacoste, Christelle Cayrou, Foteini Davrazou, Anjanabha Saha, Bradley R Cairns, Donald E Ayer, Tatiana G Kutateladze, Yang Shi, Jacques Côté, Katrin F Chua, Or Gozani
Affiliations
- PMID: 16728974
- PMCID: PMC3089773
- DOI: 10.1038/nature04835
ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression
Xiaobing Shi et al. Nature. 2006.
Abstract
Dynamic regulation of diverse nuclear processes is intimately linked to covalent modifications of chromatin. Much attention has focused on methylation at lysine 4 of histone H3 (H3K4), owing to its association with euchromatic genomic regions. H3K4 can be mono-, di- or tri-methylated. Trimethylated H3K4 (H3K4me3) is preferentially detected at active genes, and is proposed to promote gene expression through recognition by transcription-activating effector molecules. Here we identify a novel class of methylated H3K4 effector domains--the PHD domains of the ING (for inhibitor of growth) family of tumour suppressor proteins. The ING PHD domains are specific and highly robust binding modules for H3K4me3 and H3K4me2. ING2, a native subunit of a repressive mSin3a-HDAC1 histone deacetylase complex, binds with high affinity to the trimethylated species. In response to DNA damage, recognition of H3K4me3 by the ING2 PHD domain stabilizes the mSin3a-HDAC1 complex at the promoters of proliferation genes. This pathway constitutes a new mechanism by which H3K4me3 functions in active gene repression. Furthermore, ING2 modulates cellular responses to genotoxic insults, and these functions are critically dependent on ING2 interaction with H3K4me3. Together, our findings establish a pivotal role for trimethylation of H3K4 in gene repression and, potentially, tumour suppressor mechanisms.
Figures
Figure 1. The ING2 PHD domain specifically binds to H3K4me3 in vitro
a, Coomassie-blue stain of glutathione _S_-transferase (GST)–ING2PHD and GST control pull downs from calf thymus histones. b, Gel shift showing ING2PHD-binding to purified native nucleosomes. Ethidium-bromide stain of nucleosomal DNA on a non-denaturing gel. c, Western blot analysis of GST pull-down assays as in a. d, The ING2 PHD domain preferentially binds H3K4me3 peptides. Western analysis of histone peptide pull downs with the indicated GST fusion proteins and biotinylated peptides. Peptide integrity was confirmed with known methyl-lysine-binding domains (Supplementary Fig. S1d, e). aa, amino acids. e, Methylation at H3K4 is required for ING2PHD-binding to chromatin in vitro. Western analysis of GST–ING2PHD pull-down assays of chromatin purified from wild-type or Set1-null S. cerevisiae strains. f, PHD domains of yeast and human ING family proteins preferentially bind to H3K4me2/3 in histone peptide binding assays.
Figure 2. Methylated H3K4 recognition by the ING2 PHD domain enhances ING2-associated HDAC1 histone deacetylase activity in vitro
a, Western analysis of affinity-purified wild-type and mutant Flag–ING2 complexes. Mock, empty vector control immunoprecipitation. b, Binding of ING2 complexes to methylated H3K4 peptides requires an intact PHD domain. Anti-ING2 western analysis of histone peptide pull downs from the indicated HDAC1–ING2 complexes. c, Histone deacetylation by HDAC1 in wild-type, but not mutant, ING2 complexes is increased by binding of the ING2 PHD domain to methylated H3K4. Western analysis of in vitro histone deacetylation reactions by ING2 complexes in the presence or absence of methylation by SET7. Histone deacetylase inhibition with trichostatin A (TSA) is shown as a control. d, Quantification of relative histone deacetylase activity of ING2 complexes as in c from three independent experiments. Error bars indicate the s.e.m.
Figure 3. The ING2 interaction with trimethylated H3K4 occurs in vivo and requires an intact PHD domain
a, b, In vivo association of wild-type, but not PHD domain mutant, ING2 proteins with H3K4me3 at chromatin. Western analysis of proteins crosslinked in situ to wild-type or mutant Flag–ING2 proteins in protein–protein ChIPs. Note equal binding of mutant and wild-type ING2 to SAP30 (a) and HDAC1 (b). Input loaded represents 5% of total. c, Decreased H3K4me3 levels following WDR5 knockdown. Western analysis of HEK293T cells transfected with WDR5 or control RNA interference (RNAi) vectors. d, Flag–ING2 association with endogenous H3 requires H3K4me3. Western analysis of protein–protein ChIPs as in a with or without WDR5 knockdown. e, Endogenous association of H3 and ING2 requires H3K4me3. Western analysis of H3-bound proteins by protein–protein ChIP, with or without WDR5 knockdown. f, WDR5 knockdown decreases ING2 occupancy at the cyclin D1 promoter. Levels (per cent input = ChIP/input × 100) of cyclin D1 promoter and 3′ coding region sequences in the indicated ChIPs, with or without WDR5 knockdown. Error bars indicate the s.e.m. from three independent experiments.
Figure 4. Recognition of H3K4me3 by ING2 PHD domain in vivo is critical for ING2 function
a, Western analysis of ING2 expression in the indicated cell lines. *, endogenous ING2. b, ING2 is required for repression of cyclin D1 expression in response to doxorubicin (dox). Quantitative PCR of cyclin D1 mRNA, with or without doxorubicin (0.2μg ml−1, 24 h), in wild-type (“WT”), knockdown (“KD”) and knockdown reconstituted with ING2 (“KD+ING2”) cell lines. c, Impaired activity of mutant ING2 proteins in reconstitution of doxorubicin-dependent cyclin D1 repression, as in b, relative to wild-type ING2 (“KD+ING2”). In b and c, error bars indicate the s.e.m. of triplicate experiments; _P_-values < 0.01. d-f, DNA-damage-dependent increase of ING2-HDAC1 occupancy at the cyclin D1 promoter requires methylated H3K4-binding. ChIPs with antibodies to Flag (d), HDAC1 (e) and H4K8ac (f) at the cyclin D1 promoter in the indicated cell lines, with or without doxorubicin (2μM, 1 h). Error bars indicate the s.e.m. of at least three independent experiments. _P_-values < 0.05. g, Western analysis of cyclin D1 protein in the indicated cell lines with or without doxorubicin (0.2μg ml−1, 24 h). h, Impaired doxorubicin sensitivity following ING2 knockdown or reconstitution with H3K4me3-binding-defective ING2. Relative cell viability is normalized to untreated cells. Error bars indicate the s.e.m. of 3–6 independent experiments.
Comment in
- Gene regulation: a finger on the mark.
Becker PB. Becker PB. Nature. 2006 Jul 6;442(7098):31-2. doi: 10.1038/442031a. Nature. 2006. PMID: 16823438 No abstract available.
Similar articles
- Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2.
Peña PV, Davrazou F, Shi X, Walter KL, Verkhusha VV, Gozani O, Zhao R, Kutateladze TG. Peña PV, et al. Nature. 2006 Jul 6;442(7098):100-3. doi: 10.1038/nature04814. Epub 2006 May 21. Nature. 2006. PMID: 16728977 Free PMC article. - Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.
Lan F, Collins RE, De Cegli R, Alpatov R, Horton JR, Shi X, Gozani O, Cheng X, Shi Y. Lan F, et al. Nature. 2007 Aug 9;448(7154):718-22. doi: 10.1038/nature06034. Nature. 2007. PMID: 17687328 Free PMC article. - Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4.
Palacios A, Garcia P, Padró D, López-Hernández E, Martín I, Blanco FJ. Palacios A, et al. FEBS Lett. 2006 Dec 22;580(30):6903-8. doi: 10.1016/j.febslet.2006.11.055. Epub 2006 Nov 30. FEBS Lett. 2006. PMID: 17157298 - Structural insight into histone recognition by the ING PHD fingers.
Champagne KS, Kutateladze TG. Champagne KS, et al. Curr Drug Targets. 2009 May;10(5):432-41. doi: 10.2174/138945009788185040. Curr Drug Targets. 2009. PMID: 19442115 Free PMC article. Review. - The return of the INGs, histone mark sensors and phospholipid signaling effectors.
Bua DJ, Binda O. Bua DJ, et al. Curr Drug Targets. 2009 May;10(5):418-31. doi: 10.2174/138945009788185112. Curr Drug Targets. 2009. PMID: 19442114 Review.
Cited by
- Histone H4-Specific Deacetylation at Active Coding Regions by Hda1C.
Lee MK, Kim T. Lee MK, et al. Mol Cells. 2020 Oct 31;43(10):841-847. doi: 10.14348/molcells.2020.0141. Mol Cells. 2020. PMID: 32913143 Free PMC article. Review. - Effect of the tumor suppressor gene ING4 on the proliferation of MCF-7 human breast cancer cells.
Wei Q, He W, Lu Y, Yao J, Cao X. Wei Q, et al. Oncol Lett. 2012 Sep;4(3):438-442. doi: 10.3892/ol.2012.744. Epub 2012 Jun 7. Oncol Lett. 2012. PMID: 22970041 Free PMC article. - Defining the minimal peptide sequence of the ING1b tumour suppressor capable of efficiently inducing apoptosis.
Boyko A, Riabowol K. Boyko A, et al. Cell Death Discov. 2015 Oct 26;1:15048. doi: 10.1038/cddiscovery.2015.48. eCollection 2015. Cell Death Discov. 2015. PMID: 27551477 Free PMC article. - Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS, Subbanna S. Basavarajappa BS, et al. Int J Mol Sci. 2021 Apr 28;22(9):4654. doi: 10.3390/ijms22094654. Int J Mol Sci. 2021. PMID: 33925016 Free PMC article. Review. - The novel function of JADE1S in cytokinesis of epithelial cells.
Siriwardana NS, Meyer RD, Panchenko MV. Siriwardana NS, et al. Cell Cycle. 2015;14(17):2821-34. doi: 10.1080/15384101.2015.1068476. Epub 2015 Jul 7. Cell Cycle. 2015. PMID: 26151225 Free PMC article.
References
- Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–1080. - PubMed
- Kurdistani SK, Grunstein M. Histone acetylation and deacetylation in yeast. Nature Rev. Mol. Cell Biol. 2003;4:276–284. - PubMed
- Schneider R, et al. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nature Cell Biol. 2004;6:73–77. - PubMed
- Bernstein BE, et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell. 2005;120:169–181. - PubMed
- Bannister AJ, Kouzarides T. Histone methylation: recognizing the methyl mark. Methods Enzymol. 2004;376:269–288. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous